Insilico Medicine, a clinical-stage biotechnology company specializing in generative AI-driven drug discovery, has announced that its novel compound, ISM6331, has …
A global initiative is underway to create consensus definitions for diverse intelligent systems, including AI, LLMs, and biological intelligences. Led …
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications …
Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has presented significant advancements in its AI-Immunology™ platform, specifically focusing on …
French startup Bioptimus has released H-optimus-0, the largest open-source AI foundation model for pathology. With 1.1 billion parameters, this model …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.